SEMAGLUTIDE and GLAUCOMA

This report in American Journal of Ophthalmology concluded:


This systematic meta-analysis found that GLP-1 RA use is associated with reduced glaucoma development in retrospective studies. Future, well-designed, long-term studies focusing on GLP-1 RAs and SGLT-2 inhibitors are needed to validate these findings and evaluate their effects on glaucoma progression and vision loss. The overall interpretation should be cautious.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH